BFS
RVMD icon

Bare Financial Services’s Revolution Medicines RVMD Stock Holding History

Bare Financial Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31K Sell
7
-23
-77% -$3.36K ﹤0.01% 1268
2026
Q1 		$2.92K Buy
30
+23
+329% +$2.32K ﹤0.01% 857
2025
Q4 		$558 Buy
+7
New +$459 ﹤0.01% 1331

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bare Financial Services's RVMD Position: Q2 2026 in Review

Bare Financial Services reduced its Revolution Medicines (RVMD) stake by 77% in Q2 2026, selling an estimated $3.36K and leaving 7 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Bare Financial Services first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.92K in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bare Financial Services held 7 shares of Revolution Medicines worth $1.31K as of Q2 2026.
  • Bare Financial Services sold 23 Revolution Medicines shares in Q2 2026, an estimated $3.36K.
  • Revolution Medicines made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1268 holding.
  • Bare Financial Services first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • Bare Financial Services's Revolution Medicines position peaked at $2.92K in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.